Skip to main content
Figure 2 | BMC Neurology

Figure 2

From: Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study

Figure 2

Likert pain scale change from baseline in rotigotine-treated patients by A. UPDRS III responder status, and B. PDSS-2 responder status. †ANCOVA model with UPDRS III/PDSS-2 responder status and region as factors and baseline pain score as the covariate. ANCOVA: analysis of covariance; CI: confidence interval; LS: least square; PDSS-2: Parkinson’s Disease Sleep Scale; SD: standard deviation; UPDRS III: Unified Parkinson’s Disease Rating Scale.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us